Contact information
Linda Wicker
Recent publications
-
Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes.
Journal article
Robertson CC. et al, (2021), Nature genetics
-
Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD): a phase 2, multicentre, double-blind, randomized, placebo-controlled trial
Journal article
Marcovecchio ML. et al, (2020), Wellcome Open Research, 5, 49 - 49
-
Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD): a phase 2, multicentre, double-blind, randomized, placebo-controlled trial
Journal article
Marcovecchio L. et al, (2020)
-
Genetic Variants Predisposing Most Strongly to Type 1 Diabetes Diagnosed Under Age 7 Years Lie Near Candidate Genes That Function in the Immune System and in Pancreatic β-Cells.
Journal article
Inshaw JRJ. et al, (2020), Diabetes care, 43, 169 - 177
-
Stochastic search and joint fine-mapping increases accuracy and identifies previously unreported associations in immune-mediated diseases
Journal article
Asimit JL. et al, (2019), Nature Communications, 10